Back to Search
Start Over
Interferon affects nuclear proteins in cells of clinically sensitive chronic myelogenous leukemia patients.
- Source :
-
Blood [Blood] 1990 Sep 15; Vol. 76 (6), pp. 1117-30. - Publication Year :
- 1990
-
Abstract
- Cytoplasmic protein extracts from chronic myelogenous leukemia (CML) cells contained an activity that altered the electrophoretic mobility of complexes formed between nuclear proteins and the transcriptional enhancers of interferon (IFN)-inducible genes. Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes. The presence of clinical responsiveness to IFN-alpha correlated with the sensitivity to the IFN-induced change in the electrophoretic mobility of nuclear protein-DNA complexes. These data suggest that the action of IFN-alpha in CML may be linked to a pathway that can result in posttranslational modification of nuclear proteins.
- Subjects :
- Base Sequence
Blood Cells analysis
Blood Cells cytology
Bone Marrow analysis
Bone Marrow Cells
Humans
Injections, Subcutaneous
Interferon Type I administration & dosage
Interferon Type I metabolism
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Molecular Sequence Data
Nuclear Proteins genetics
Nuclear Proteins metabolism
Oligonucleotides genetics
Transcription Factors analysis
Transcription Factors genetics
Transcription Factors metabolism
Interferon Type I pharmacology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive pathology
Nuclear Proteins analysis
Subjects
Details
- Language :
- English
- ISSN :
- 0006-4971
- Volume :
- 76
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Academic Journal
- Accession number :
- 2400807